<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01337206</url>
  </required_header>
  <id_info>
    <org_study_id>09-024</org_study_id>
    <nct_id>NCT01337206</nct_id>
  </id_info>
  <brief_title>SX ELLA Esophageal Degradable BD Stent System</brief_title>
  <acronym>DESTINY</acronym>
  <official_title>Evaluation of the Effectiveness of the SX ELLA Esophageal Degradable BD (BD Stent) Stent System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook Group Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook Group Incorporated</source>
  <brief_summary>
    <textblock>
      The SX-ELLA Stent Esophageal Degradable BD (BD Stent) is designed for dilation of benign
      esophageal lesions, namely: (1) stenosis (peptic, anastomotic or caustic) refractory to
      standard therapy, (2) achalasia refractory to standard therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The average number of dilations per patient within 3 months / 6 months following placement of an ELLA stent</measure>
    <time_frame>3 - 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients remaining dysphagia and stricture free within 6 and 12 months after inclusion</measure>
    <time_frame>6 - 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to recurrent significant dysphagia</measure>
    <time_frame>6 - 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to dilation of recurrent stricture</measure>
    <time_frame>6 - 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 months and 12 months incidence of repeat dilation</measure>
    <time_frame>6 - 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious and minor adverse events with possible or likely relation to the study Intervention</measure>
    <time_frame>6 - 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct medicals costs: procedures, secondary interventions</measure>
    <time_frame>6 - 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>6 - 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>6 - 12 months</time_frame>
    <description>Observing proper deployment and placement of stent using endoscopic and radiographic imaging.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of presence of gold markers within the region of the esophagus at 3 months, if possible</measure>
    <time_frame>6 - 12 months</time_frame>
    <description>Assessment of presence of gold markers within the region of the esophagus at 3 months, using radiographic imaging, if possible, to check for remaining sections of stent that have not yet degraded.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Benign Esophageal Lesions</condition>
  <arm_group>
    <arm_group_label>Stenting Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stenting Arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dilation Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dilation Arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stenting with ELLA Biodegradable stent</intervention_name>
    <description>Treating benign esophageal lesions with the placement of a degradable stent</description>
    <arm_group_label>Stenting Arm</arm_group_label>
    <other_name>Esophageal Stenting</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard Dilations</intervention_name>
    <description>Treating benign esophageal lesions with standard dilation therapy</description>
    <arm_group_label>Dilation Arm</arm_group_label>
    <other_name>Bougie Dilation, Balloon Dilation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A recurrent benign esophageal stricture due to all causes (surgery, radiation therapy,
             corrosive ingestion, peptic injury, PDT, or other ablative therapy)

        Exclusion Criteria:

          -  Patient &lt; 18 years old

          -  Patient is unwilling or unable to sign and date the informed consent

          -  Patient is unwilling or unable to comply with the follow-up schedule

          -  Patient is pregnant, breast-feeding, or planning to become pregnant in the next 12
             months

          -  Patient is simultaneously participating in another drug or device study or the patient
             has completed the follow-up phase for the primary objective of any previous study less
             than 30 days prior to enrollment in this study

          -  Patient with a life expectancy &lt; 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter D. Siersema, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Utrech</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinique Universitaire Saint Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Istituto Clinico Humanitas</name>
      <address>
        <city>Milan</city>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>22700</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Utrech</name>
      <address>
        <city>Utrecht</city>
        <zip>3508</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Ciudad Real</name>
      <address>
        <city>Ciudad Real</city>
        <zip>13005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University College of London Hospital</name>
      <address>
        <city>London</city>
        <zip>NW1 2PG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2011</study_first_submitted>
  <study_first_submitted_qc>April 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2011</study_first_posted>
  <last_update_submitted>February 5, 2015</last_update_submitted>
  <last_update_submitted_qc>February 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Esophageal Stenosis</keyword>
  <keyword>Esopageal Strictures</keyword>
  <keyword>Esophageal Dysphagia</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

